EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
3.4.23.39 | 4-(4-dimethylaminophenylazo)benzoyl-CH2-CH2-CO-ALERMFLSFP-diaminopimelate-5-[(2-aminoethyl)amino]naphthalene-1-sulfonic acid + H2O |
- |
Plasmodium falciparum |
? |
- |
? |
3.4.23.39 | 4-(4-dimethylaminophenylazo)benzoyl-CH2-CH2-CO-CO-ALERMFLSFP-diaminopimelate-5-[(2-aminoethyl)amino]naphthalene-1-sulfonic acid + H2O |
- |
Plasmodium falciparum |
? |
- |
? |
3.4.23.39 | 4-(4-dimethylaminophenylazo)benzoyl-CH2-CH2-CO-ERMFLSFP-diaminopimelate-5-[(2-aminoethyl)amino]naphthalene-1-sulfonic acid + H2O |
- |
Plasmodium falciparum |
? |
- |
? |
3.4.23.39 | 4-[[4'-(dimethylamino)phenyl]azo]-benzoyl-Glu-Arg-Met-Phe-Leu-Ser-Phe-Pro-(gamma-aminobutyryl)-5-[(2'-aminoethyl)-amino]naphthalenesulfonic acid + H2O |
- |
Plasmodium falciparum |
? |
- |
? |
3.4.23.39 | 4-[[4'-(dimethylamino)phenyl]azo]-benzoyl-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-5-[(2'-aminoethyl)-amino]naphthalenesulfonic acid + H2O |
- |
Plasmodium falciparum |
? |
- |
? |
3.4.23.39 | actin + H2O |
- |
Plasmodium falciparum |
? |
- |
? |
3.4.23.39 | DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS + H2O |
FRET substrate, substrate is designed to mimic the hemoglobin cleavage site. The substrate is conjugated with the fluorescent donor EDANS and the quencher DABCYL |
Plasmodium falciparum |
? |
- |
? |
3.4.23.39 | DABCYL-L-Glu-L-Arg-L-Nle-L-Phe-L-Leu-L-Ser-L-Phe-L-Pro-EDANS + H2O |
FRET-based substrate |
Plasmodium falciparum |
? |
- |
? |
3.4.23.39 | EDANS-CO-CH2-CH2-CO-Ala-Leu-Glu-Arg-Met-Phe-Leu-Ser-Phe-Pro-Dap-(DABCYL)-OH + H2O |
- |
Plasmodium falciparum |
? |
- |
? |
3.4.23.39 | EDANS-CO-CH2-CH2-CO-Ala-Leu-Glu-Arg-Met-Phe-Leu-Ser-Phe-Pro-Dap-(DABCYL)-OH + H2O |
quenched fluorescent peptide substrate |
Plasmodium falciparum |
? |
- |
? |